Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Probability Laws

Probability Laws

Law of Segregation

Law of Segregation

When crossing pea plants, Mendel noticed that one of the parental traits would sometimes disappear in the first generation of offspring, called the F1 generation, and could reappear in the next generation (F2). He concluded that one of the traits must be dominant over the other, thereby causing masking of one trait in the F1 generation. When he crossed the F1 plants, he found that 75% of the offspring in the F2 generation had the dominant phenotype, while 25% had the recessive phenotype.

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Echo

Echo

The human ear cannot distinguish between two sources of sound if they happen to reach within a specific time interval, typically 0.1 seconds apart. More than this, and they are perceived as separate sources.
Imagine the sound is reflected back to the ears. Assuming that the source is very close to the human, the difference between hearing the two sounds—the emitted sound and the reflected sound—may be more than the minimum time for perceiving distinct sounds. If this is the case,...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Enzyme Inhibition

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reply to 'Methodological concerns and a lack of evidence for reforming regulatory exclusivities for pharmaceuticals'.

Nature biotechnology·2026

Same author

Modification patents across multiple NDAs in pharmaceutical protections.

Health affairs scholar·2026

Same author

Tear down the wall: why requiring the FDA and the PTO to share information will improve the decision-making of both agencies.

Journal of law and the biosciences·2026

Same author

The New Clinical Investigation exclusivity: a substantial source of monopoly time for brand drugs.

Nature biotechnology·2025

Same author

Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act.

PLoS medicine·2024

Same author

NIH Licensing Would Benefit from Free-Market Provisions.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2024

Search research articles

Related Experiment Video

Updated: Mar 13, 2026

In Vitro Transcription Assays and Their Application in Drug Discovery

In Vitro Transcription Assays and Their Application in Drug Discovery

Published on: September 20, 2016

Universities and Patent Demands.

Andrew K Cordova¹, Robin Feldman²

¹Program Associate at the Institute for Innovation Law, University of California Hastings College of the Law.

Journal of Law and the Biosciences

|October 25, 2016

Summary

Academic institutions face challenges as gene mutation patents impede Alzheimer's research. This trend, driven by non-practicing entities, risks misusing public funds and harming research progress.

More Related Videos

Synthesis of Graphene-Hydroxyapatite Nanocomposites for Potential Use in Bone Tissue Engineering

Synthesis of Graphene-Hydroxyapatite Nanocomposites for Potential Use in Bone Tissue Engineering

Published on: July 27, 2022

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

Related Experiment Videos

Last Updated: Mar 13, 2026

In Vitro Transcription Assays and Their Application in Drug Discovery

In Vitro Transcription Assays and Their Application in Drug Discovery

Published on: September 20, 2016

Synthesis of Graphene-Hydroxyapatite Nanocomposites for Potential Use in Bone Tissue Engineering

Synthesis of Graphene-Hydroxyapatite Nanocomposites for Potential Use in Bone Tissue Engineering

Published on: July 27, 2022

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

Area of Science:

Biomedical research
Intellectual property law
Medical ethics

Background:

Research universities are crucial for medical advancements.
Academic researchers collaborate with industry, leading to breakthroughs.
A specific case highlights gene mutation patent issues impacting Alzheimer's research.

Purpose of the Study:

To analyze the impact of gene mutation patents on academic research.
To examine the role of non-practicing entities in academic research funding.
To discuss the ethical implications of patent law on medical innovation.

Main Methods:

Case study analysis of a specific gene mutation patent.
Review of trends in academic research and intellectual property.
Discussion of the non-practicing entity business model.

Main Results:

Gene mutation patents can create significant impediments to research, as exemplified by the Alzheimer's research case.
The proliferation of non-practicing entities is increasingly involving academic institutions.
Potential misuse of public research funds for financial gain is a growing concern.

Conclusions:

Academic institutions must balance intellectual property interests with their role in advancing science.
The trend of patenting research tools may hinder scientific progress and public benefit.
Legislators and the public may view the use of taxpayer money for patent extraction negatively.